Breaking

Archive

Dec 2021 1 result
16:15
16:15

UVRI to Study Moderna, Sanofi Efficacy in Protecting People at Risk of Critical COVID-19 Ministry of Health 2

She said participants will be divided into three groups. The first one will get one jab, the other two jabs, and the last one three jabs to see if they get protected against developing the symptomatic disease, critical illness requiring hospitalization, and if they are protected against emerging variants such as the latest omicron variant.
Dec 2021 1 result